<DOC>
	<DOCNO>NCT02835092</DOCNO>
	<brief_summary>The study evaluate effect two commercially available weight loss program , TSFL MEDD program , compare self-directed control diet , change body weight 16-week weight loss phase , apparently healthy overweight obese men woman .</brief_summary>
	<brief_title>Weight Loss Using Take Shape For Life Program Medifast Direct Program Versus Self-Directed Diet</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Participant judge Clinical Investigator good health basis medical history screen laboratory assessment . Participant BMI 27.0 42.0 kg/m2 start intervention . Participant plan change smoke habit study period . Participant willing able comply visit schedule . Participant willing modify physical activity level accordance recommendation provide group . In Clinical Investigator 's opinion , participant interest lose weight , ready willing . Participant willing/able follow assign plan adhere food beverage consumption guideline duration study period . Participant access internet via computer , tablet , and/or smart phone . Participant understand study procedure sign form provide informed consent participate study authorization release relevant protect health information study Clinical Investigators . Participant abnormal laboratory test result clinical significance screen visit , discretion Clinical Investigator . Participant weight loss gain &gt; 5 % 6 month prior screen visit except case postpartum weight loss . Participant extreme dietary habit , include vegetarianism , judgment Clinical Investigator . Participant use medication , product , supplement , and/or programs/diets intend alter body weight within 6 month screen visit . Participant use medication know stimulate suppress appetite , and/or alter body weight take indication , allow long dose remain stable past 6 month . Participant use thyroid hormone , except stabledose replacement therapy ≥2 month prior screen visit . Participant use Coumadin® ( warfarin ) , and/or medication may influence lipid and/or blood pressure , except stabledose medication 1 month prior screen visit . Participant use medication may influence carbohydrate metabolism , include limited hypoglycemic medication systemic ( intravenous , intramuscular , oral ) corticosteroid within 1 month screen visit . Participant use lithium within 1 month screen visit . Participant history surgery liposuction weight reduce purpose . Participant history presence clinically important gout , cardiac , renal , hepatic , endocrine ( type 1 diabetes mellitus type 2 diabetes mellitus require medication ) , pulmonary , biliary , pancreatic , neurologic disorder . Participant history eat disorder ( e.g. , anorexia nervosa , bulimia nervosa binge eat ) diagnose health professional . Participant uncontrolled hypertension ( systolic blood pressure ≥160 mm Hg diastolic blood pressure ≥100 mm Hg ) define blood pressure measure screening visit . Participant history presence cancer prior 2 year , except nonmelanoma skin cancer . Participant elective hospitalization plan ( e.g. , elective cosmetic procedure ) study period . Participant female pregnant , plan pregnant study period , lactating , childbearing potential unwilling commit use medically approve form contraception throughout study period . Participant recent history ( within 12 month Visit 1 ; week 1 ) strong potential alcohol substance abuse . Alcohol abuse define &gt; 14 drinks/week ( 1 drink = 12 oz beer , 5 oz wine , 1½ oz distil spirit ) . Participant known allergy , sensitivity , intolerance study food ingredient ( ) study diet ( e.g. , soy , gluten , wheat , lactose ) . Exposure nonregistered drug product within 1 month prior screen visit . Participant condition Clinical Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result put person undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>